rhG-CSF

DRUG10 trials

Conditions

Breast CancerCervical CancerChemotherapy-induced NeutropeniaCost-Benefit AnalysisGranulocyte Colony-Stimulating FactorHemophagocytic SyndromeLymphomaLymphoma, Non-Hodgkin

Phase 2

Mecapegfilgrastim(PEG-G-CSF) for Prophylaxis of Chemotherapy-induced Neutropenia in Patients With Lymphoma

NCT04460508

The First Hospital of Jilin UniversityChemotherapy-induced Neutropenia, Lymphoma

Start: 2020-12-20End: 2023-03-20Target: 170Updated: 2022-07-07

Study on the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia During Concurrent Chemoradiotherapy of Cervical Cancer

CompletedNCT04542356

Chongqing University Cancer HospitalCervical Cancer

Start: 2018-08-01End: 2021-05-26Updated: 2023-09-06

Phase 4

PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy

CompletedNCT02805153

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.Breast Cancer

Start: 2013-04-30End: 2016-02-29Updated: 2016-06-20

PEG-rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation

NCT02905942

Peking UniversityLymphoma

Start: 2015-12-31Target: 96Updated: 2016-09-19

To Evaluate the Efficacy and Safety of PEG-rhG-CSF（Jinyouli®） in Reducing Neutropenia in Patients With Cervical Cancer

NCT03206684

Air Force Military Medical University, ChinaCervical Cancer

Start: 2017-08-31End: 2018-09-30Target: 20Updated: 2017-08-28

Cost-Effectiveness Study of PEG-rhG-CSF in Prophylactic Treatment of Neutropenia After Chemotherapy in Lymphoma

NCT04083079

Ruijin HospitalCost-Benefit Analysis, Granulocyte Colony-Stimulating Factor, Lymphoma, Non-Hodgkin

Start: 2019-08-01End: 2022-04-01Target: 250Updated: 2019-09-10

Clinical Study on PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells

NCT06026995

Chongqing University Cancer HospitalLymphoma

Start: 2022-03-01End: 2024-06-01Target: 174Updated: 2023-09-07

Unknown Phase

Evaluate the Efficacy and Safety of PEG-rhG-CSF in Patients With Hemophagocytic Syndrome

NCT04500886

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.Hemophagocytic Syndrome

Start: 2020-08-01End: 2022-09-01Target: 50Updated: 2020-08-05

PEG-rhG-CSF Compared With rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation

NCT05156554

Sun Yat-sen UniversityLymphoma

Start: 2021-12-31End: 2023-01-31Target: 80Updated: 2021-12-14

the Efficacy and Safety of PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells in Lymphoma

NCT05834751

Ou Bai, MD/PHDLymphoma

Start: 2023-05-01End: 2025-07-01Target: 144Updated: 2023-04-28

Related Papers

Polyethylene glycol-conjugated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) primary prophylaxis significantly reduces the duration of neutropenia in non-Hodgkin's lymphoma patients treated with chemotherapy: a randomised trial (NCT05834751).

2025-12-29

Clinical study on the efficacy and safety of pegylated recombinant human granulocyte colony-stimulating factor injection (PEG-rhG-CSF) in autologous hematopoietic stem cell mobilization for lymphoma - Results of interim analysis

Blood2025-11-03

A clinical study of pegylated recombinant human granulocyte colony stimulating factor (PEG-rhG-CSF) in preventing neutropenia during concurrent chemoradiotherapy of cervical cancer

BMC Cancer2021-06-0220 citations